Month: December 2017

Systemic Lupus Erythematosus (SLE) – Market Is Expected to Grow with Upcoming Therapies

Articles

Systemic Lupus Erythematosus (SLE) is a chronic, multisystem, inflammatory autoimmune disease which leads to weakening of the immune...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant, Uncategorized

Positive Phase 2 data for Roche’s lymphoma ADC Roche’s antibody-drug conjugate for non-Hodgkin lymphoma polatuzumab has already...

Read More

Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail, Uncategorized

AbbVie aims for best-in-class psoriasis prospect The last few years have seen a wave of new biologics take the psoriasis market by storm....

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

KINECT 4 Phase III Study Demonstrating INGREZZA® Improves Tardive Dyskinesia Symptoms Neurocrine Biosciences, Inc. announced new long-term...

Read More
Close